Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress von Gallogly, Molly M, Mieyal, John J

Volltext

Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation von Gallogly, Molly M, Starke, David W, Mieyal, John J

Volltext

Kinetic and Mechanistic Characterization and Versatile Catalytic Properties of Mammalian Glutaredoxin 2: Implications for Intracellular Roles von Gallogly, Molly M, Starke, David W, Leonberg, Amanda K, Ospina, Susan M. English, Mieyal, John J

Volltext

Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy von Caimi, P. F., Cashen, A., Gallogly, M., Winter, A., Boughan, K., Ghobadi, A., Jagadeesh, D., Cooper, B., Mehta‐Shah, N., Dean, R., Metheny, L., Pohlman, B., Bartlett, N. L., Lima, M., Kahl, B. S., Hill, B. T.

Volltext

Molecular mechanisms and clinical implications of reversible protein S-glutathionylation von Mieyal, John J, Gallogly, Molly M, Qanungo, Suparna, Sabens, Elizabeth A, Shelton, Melissa D

Volltext

Covalent Cross-Linking of Glutathione and Carnosine to Proteins by 4-Oxo-2-nonenal von Zhu, Xiaochun, Gallogly, Molly M, Mieyal, John J, Anderson, Vernon E, Sayre, Lawrence M

Volltext

SAFETY AND EFFICACY OF VENETOCLAX COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (VICER) FOR TREATMENT OF RELAPSED DLBCL: FINAL RESULTS FROM THE PHASE 1TRIAL von Caimi, P.F., Jagadeesh, D., Boughan, K., Dean, R., Cooper, B., Pohlman, B., Gallogly, M., Ondrejka, S., Moore, E., Oduro, K., Hsi, E.D., Lima, M., Hill, B.T.

Volltext

Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis von Gallogly, Molly M., Lazarus, Hillard M., Cooper, Brenda W.

Volltext

A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia von Tomlinson, Benjamin K., Gallogly, Molly M., Kane, Donna M., Metheny, Leland, Lazarus, Hillard M., William, Basem M., Craig, Michael D., Levis, Mark J., Cooper, Brenda W.

Volltext

Glutaredoxin Regulates Apoptosis in Cardiomyocytes via NFκB Targets Bcl-2 and Bcl-xL: Implications for Cardiac Aging von Gallogly, Molly M, Shelton, Melissa D, Qanungo, Suparna, Pai, Harish V, Starke, David W, Hoppel, Charles L, Lesnefsky, Edward J, Mieyal, John J

Volltext

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 von Caimi, P F, Cashen, A, Gallogly, M, Winter, A, Boughan, K, Ghobadi, A, Jagadeesh, D, Cooper, B, Mehta-Shah, N, Dean, R, Metheny, L, Pohlman, B, Bartlett, N L, de Lima, M, Kahl, B S, Hill, B T

Volltext

Grafting of Massive Tibial Subchondral Bone Defects in a Caprine Model Using β-Tricalcium Phosphate Versus Autograft von Wheeler, Donna L, Cross, Alan R, Eschbach, Elizabeth J, Rose, Alex T, Gallogly, Paul M, Lewis, Dan D, Vander Griend, Robert A

Volltext

Improving Quality of Care for Acute Myocardial Infarction: The Guidelines Applied in Practice (GAP) Initiative von Mehta, Rajendra H, Montoye, Cecelia K, Gallogly, Meg, Baker, Patricia, Blount, Angela, Faul, Jessica, Roychoudhury, Canopy, Borzak, Steven, Fox, Susan, Franklin, Mary, Freundl, Marge, Kline-Rogers, Eva, LaLonde, Thomas, Orza, Michele, Parrish, Robert, Satwicz, Martha, Smith, Mary Jo, Sobotka, Paul, Winston, Stuart, Riba, Arthur A, Eagle, Kim A

Volltext

AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report von Elmi, Adily N., Heinemann, Scott D., van Besien, Koen, Gallogly, Molly M.

Volltext

AML-181 AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report von Elmi, Adily N., Heinemann, Scott D., van Besien, Koen, Gallogly, Molly M.

Volltext

The Prognostic Factors for Early Fatal Outcome in Patients with Multiple Myeloma von Vuyyala, Sowjanya, Chamoun, Kamal, Fu, Pingfu, Cao, Shufen, Gallogly, Molly M, de Lima, Marcos, Malek, Ehsan

Volltext

Patient Selection Bias Limits the Real World Efficacy of Randomized Clinical Trials in Multiple Myeloma von Eduafo, Augusta, Metheny, Leland, Driscoll, James, Tomlinson, Benjamin K., Boughan, Kirsten M, Gallogly, Molly M, de Lima, Marcos, Malek, Ehsan

Volltext

PHASE 1 STUDY OF ANTICD19 CAR‐T CELLS WITH TNFα TRANSMEMBRANE DOMAIN AND 41BB, CD3ζ COSTIMULATORY DOMAINS. RESPONSES IN SUBJECTS WITH RAPIDLY PROGRESSIVE LYMPHOMA von Caimi, P.F., Reese‐Koc, J.S., Otegbeye, F., Schneider, D., Chamoun, K., Boughan, K.M., Cooper, B.W., Galloway, E., Gallogly, M.M., Kruger, W., Worden, A., Kadan, M., Malek, E., Metheny, L., Tomlinson, B., Wald, D.N., Sekaly, R.P., Orentas, R., Dropulic, B., Lima, M.

Volltext

Small Molecule Activators of Protein Phosphatase 2A (SMAPs) Cause c-Myc Degradation and Tumor Growth Suppression in Preclinical Models of Lymphoid Malignancies von Gallogly, Molly M, Yuan, Eric, Mazhar, Sahar, Farrington, Caroline, Narla, Goutham

Volltext

Midostaurin: an emerging treatment for acute myeloid leukemia patients von Gallogly, Molly Megan, Lazarus, Hillard M

Volltext